These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 23280993)

  • 81. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia.
    Kilic E; Kilic U; Wang Y; Bassetti CL; Marti HH; Hermann DM
    FASEB J; 2006 Jun; 20(8):1185-7. PubMed ID: 16641198
    [TBL] [Abstract][Full Text] [Related]  

  • 82. tPA in the central nervous system: relations between tPA and cell surface LRPs.
    Ortolano S; Spuch C
    Recent Pat Endocr Metab Immune Drug Discov; 2013 Jan; 7(1):65-76. PubMed ID: 23231415
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.
    Kilic E; Kilic U; Matter CM; Lüscher TF; Bassetti CL; Hermann DM
    Stroke; 2005 Feb; 36(2):332-6. PubMed ID: 15625301
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke.
    Li M; Chen S; Shi X; Lyu C; Zhang Y; Tan M; Wang C; Zang N; Liu X; Hu Y; Shen J; Zhou L; Gu Y
    J Neuroinflammation; 2018 Aug; 15(1):237. PubMed ID: 30139371
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Isoflurane preconditioning inhibits the effects of tissue-type plasminogen activator on brain endothelial cell in an
    Cheon SY; Kim SY; Kam EH; Lee JH; Kim JM; Kim EJ; Kim TW; Koo BN
    Int J Med Sci; 2017; 14(5):425-433. PubMed ID: 28539818
    [TBL] [Abstract][Full Text] [Related]  

  • 86. SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells.
    Gerzanich V; Kwon MS; Woo SK; Ivanov A; Simard JM
    PLoS One; 2018; 13(4):e0195526. PubMed ID: 29617457
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease.
    Rossato P; Glantschnig H; Canneva F; Schuster M; Coulibaly S; Schrenk G; Voelkel D; Dockal M; Plaimauer B; Rottensteiner H; Gritsch H; Federti E; Matte A; De Franceschi L; Scheiflinger F; Hoellriegl W
    J Thromb Haemost; 2023 Feb; 21(2):269-275. PubMed ID: 36700507
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis.
    Kelly MA; Shuaib A; Todd KG
    Exp Neurol; 2006 Jul; 200(1):38-49. PubMed ID: 16624294
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Early ischemic blood brain barrier damage: a potential indicator for hemorrhagic transformation following tissue plasminogen activator (tPA) thrombolysis?
    Jin X; Liu J; Liu W
    Curr Neurovasc Res; 2014; 11(3):254-62. PubMed ID: 24875486
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Retinoic acid ameliorates blood-brain barrier disruption following ischemic stroke in rats.
    Kong L; Wang Y; Wang XJ; Wang XT; Zhao Y; Wang LM; Chen ZY
    Pharmacol Res; 2015 Sep; 99():125-36. PubMed ID: 26066585
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Functional occurrence of the interaction of tissue plasminogen activator with the NR1 Subunit of N-methyl-D-aspartate receptors during stroke.
    Macrez R; Bezin L; Le Mauff B; Ali C; Vivien D
    Stroke; 2010 Dec; 41(12):2950-5. PubMed ID: 20966414
    [TBL] [Abstract][Full Text] [Related]  

  • 92. t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions.
    Freeman R; Niego B; Croucher DR; Pedersen LO; Medcalf RL
    Brain Res; 2014 May; 1565():63-73. PubMed ID: 24675027
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cilostazol reduces the risk of hemorrhagic infarction after administration of tissue-type plasminogen activator in a murine stroke model.
    Kasahara Y; Nakagomi T; Matsuyama T; Stern D; Taguchi A
    Stroke; 2012 Feb; 43(2):499-506. PubMed ID: 22033992
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Very Mild Hypothermia (35°C) Postischemia Reduces Infarct Volume and Blood/Brain Barrier Breakdown Following tPA Treatment in the Mouse.
    Cechmanek BK; Tuor UI; Rushforth D; Barber PA
    Ther Hypothermia Temp Manag; 2015 Dec; 5(4):203-8. PubMed ID: 26075540
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The Role of von Willebrand Factor, ADAMTS13, and Cerebral Artery Thrombus Composition in Patient Outcome Following Mechanical Thrombectomy for Acute Ischemic Stroke.
    Prochazka V; Jonszta T; Czerny D; Krajca J; Roubec M; Macak J; Kovar P; Kovarova P; Pulcer M; Zoubkova R; Lochman I; Svachova V; Pavliska L; Vrtkova A; Kasprak D; Gumulec J; Weisel JW
    Med Sci Monit; 2018 Jun; 24():3929-3945. PubMed ID: 29887594
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury.
    Reddrop C; Moldrich RX; Beart PM; Farso M; Liberatore GT; Howells DW; Petersen KU; Schleuning WD; Medcalf RL
    Stroke; 2005 Jun; 36(6):1241-6. PubMed ID: 15879331
    [TBL] [Abstract][Full Text] [Related]  

  • 97. HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator.
    Roussel BD; Mysiorek C; Rouhiainen A; Jullienne A; Parcq J; Hommet Y; Culot M; Berezowski V; Cecchelli R; Rauvala H; Vivien D; Ali C
    J Cell Sci; 2011 Jun; 124(Pt 12):2070-6. PubMed ID: 21610098
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection.
    Liu XS; Zhang ZG; Zhang L; Morris DC; Kapke A; Lu M; Chopp M
    J Cereb Blood Flow Metab; 2006 Jun; 26(6):787-96. PubMed ID: 16177809
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Tissue plasminogen activator extravasated through the cerebral vessels: evaluation using a rat thromboembolic stroke model.
    Harada T; Kano T; Katayama Y; Matsuzaki T; Tejima E; Koshinaga M
    Thromb Haemost; 2005 Oct; 94(4):791-6. PubMed ID: 16270632
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
    Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
    J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.